Comparisons
The two-option questions people actually ask — compared factually, with the differences that matter and an honest 'which, for whom.' Education only.
Two research peptides popular for recovery. Both are largely backed by preclinical (animal) data, both are not FDA-approved, and both are prohibited in sport.
Two GHRH analogs used to stimulate the body's own growth hormone. They differ mainly in half-life and duration of action.
Two prescription incretin medications for weight and metabolic health. Tirzepatide acts on two receptors (GIP + GLP-1); semaglutide on one (GLP-1).
Two very different approaches to low testosterone: stimulate your own production, or replace it. The fertility implications differ significantly.
NMN is a precursor the body converts toward NAD+, a coenzyme central to energy metabolism. Both are popular in longevity circles; human evidence is early.
If you'd like help applying any of this to your own health, schedule a consultation with the Bearing team.